ghk cu powder form Epitalon (Epithalon) Tetrapeptide Research full-size TB-500:10mg Vial

ghk cu powder form Epitalon (Epithalon) Tetrapeptide Research full-size TB-500:10mg Vial

Epitalon (Epithalon) Tetrapeptide Research Compound (10mg)

In about 17,600 adults with overweight or obesity, established cardiovascular disease, and no diabetes, the primary cardiac composite occurred in 6.5% assigned to semaglutide and 8.0% assigned to placebo over roughly 40 months (HR 0.80, 95% CI 0.72–0.90).³ This is a secondary-prevention result in people who already had cardiovascular disease, not a fixed-dose comparison or a general heart-health claim

full-size

TB-500:10mg Vial

[DOI] [PubMed] [Google Scholar] 359.Sharp RE, Chapman SK